Dongkook Pharmaceutical Co LtdDongkook Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The page is a zero-cost Environmental, Social and Governance analysis for Dongkook Pharmaceutical Co Ltd. The SDG score for Dongkook Pharmaceutical Co Ltd represents the company's transparency towards the United Nations SDGs. This Disclosure score covers 17 United Nations Sustainable Development Goals including: 'Zero Hunger', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'.

Dongkook Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.1; made up of an environmental score of 1.6, social score of 1.6 and governance score of 0.0.

SDG Transparency Score for Dongkook Pharmaceutical Co Ltd 

1.1

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Dongkook Pharmaceutical Co Ltd 
1.6

Environmental

1.6

Social

0.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
2477Uniworth International Ltd
1.2
Low
2477Slottsviken Fastighetsaktiebolag (publ)
1.2
Low
2499Dongkook Pharmaceutical Co Ltd
1.1
Low
2499Anhui Fengyuan Pharmaceutical Co Ltd
1.1
Low
2499Avadel Pharmaceuticals PLC
1.1
Low
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Dongkook Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Dongkook Pharmaceutical Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Dongkook Pharmaceutical Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Dongkook Pharmaceutical Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Dongkook Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Dongkook Pharmaceutical Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Dongkook Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

Sorry!

Failed to process!